9.00 am – 12.00 pm

Session V: Therapeutic Applications of Gene Editing
Gene Editing for Primary Immunodeficiencies, Suk See DE RAVIN
Optimizing homology-directed repair of DNA breaks in hematopoietic stem cells, Paula CANNON
Correction of Duchenne Muscular Dystrophy by Genome Editing, Eric OLSON
Gene edited T cell therapies for leukaemia, Waseem QASIM
Editing population genetics for vector control, Andrea CRISANTI

9.30 am – 12.00 pm

Session II: Advances in Genome Editing
Base Editing: Genome Editing Without Double-Stranded DNA Cleavage, Nicole GAUDELLI
Structures, mechanisms and engineering of CRISPR-Cas genome editors, Martin JINEK
Genome Engineering Technologies for Programming and Recoding Organisms, Farren ISAACS
RNA modulation by RNA-targeting Cas proteins, Gene YEO

1.45 – 3.15 pm

Session III: CRISPRs as a Discovery Tool
CRISPR/Cas9 mediated genome editing in mice and its application for the study of reproduction, Mashito IKAWA
New frontiers in functional genomics using high-throughput genome engineering, Neville SANJANA
CRISPR tools to study and fight pathogenic bacteria, David BIKARD

3.45 – 4.45 pm

Session IV: Panel discussion: Scientific and Translational Challenges for Genome Editing
Paula CANNON, Andrea CRISANTI, Farren ISAACS, Waseem QASIM & Neville SANJANA

3.30 – 4.30 pm

Session I: CRISPRs for Attack and Defense
Adaptation mechanisms in CRISPR-Cas immunity, Dipali SASHITAL
Beyond CRISPR: anti-phage defense in the wild, Rotem SOREK